GE Capabilities Showcase

San Diego - Cell Therapy and Bioprocess 

June 22, 2018

Presenters
Abstracts
Learn More About Enterprise Solutions 
The exclusive company tour is a fantastic opportunity for companies to enjoy a product portfolio tour, followed by a round table discussion, with the GE Life Sciences team.
Space is limited. Please contact 
Melissa White, 
Cell Therapy Sales Specialist, to reserve your space today.

Event Agenda

9:00 AM – 11:15 AM: Exclusive Company Tours/ Ask the Experts

11:15 AM – 11:30 AM: Break

11:30 AM – 12:00 PM: Open Networking Session

12:00 PM – 1:30 PM: Lunch and Keynote 

  • Challenges with Cryopreservation
  • Enhance Process Efficiency and Product Quality Using Perfusion

1:30 PM – 1:45 PM: Break

1:45 PM – 3:30 PM: Exclusive Company Tours/ Ask the Experts

 

Event Details

Date: Friday, June 22, 2018
Time: 9:30 AM-3:30 PM
Location:

Farmer & The Seahorse

10996 Torreyana Road

 San Diego, CA 92121

Americana - indoor + outdoor space 
 

 

Abstracts

 

Challenges with Cryopreservation

Cryopreservation is a key element of the cell therapy workflow and provides numerous benefits such as: extending the shelf-life and integrity of cells, improving batch consistency, enhancing quality control and reducing the (COGS) Cost of Goods Sold. This presentation will provide an overview of cryopreservation and we will discuss some current challenges faced in the industry with cellular damage (during the freezing and thawing of cells) and some potential solutions. We will also discuss how workflows in the “Cryochain” are affected by scale-up and scale-out and discuss the benefits of standardizing the freezing and thawing processes.

 
 
Enhance Process Efficiency and Product Quality Using Perfusion

The field of bioproduction is rapidly evolving, as new trends and a constant need of competitiveness demand incorporation of novel technologies to meet incurred challenges. In this perspective, continuous processing is receiving high interest and is now considered for different levels, from the seed bioreactor (or N-1 step) only and up to a fully integrated process, comprising upstream production and downstream purification. Continuous processing creates great opportunities for reducing costs and improving process efficiency and product quality. This presentation will focus on upstream processing, and key points to consider when developing a perfusion cell culture process will be discussed. Development strategies, scale-down models, and the potential benefits that can be achieved with a perfusion process will be demonstrated.

Click 
here 
for information on GE Cell Therapy Enterprise, VIA Freeze, Via Thaw and Mycyrochain.

Presenters

John Morris

John Morris

Ph.D.  - CEO, Asymptote, Ltd, A GE Healthcare Company
John Morris is the CEO of Asymptote, Ltd. that makes pioneering technologies that challenge standard cell cryopreservation and thawing practices and support cGMP. In April 2017 the company was acquired by GE Healthcare. John did his PhD on the cryobiology of T cells within the MRC division of Cryobiology at the Clinical Research Centre, Harrow, in the 1970’s. Since then he has published over 100 papers in peer reviewed journals on the science of cryobiology. After gaining is PhD he worked for 8 years as a research scientist with the Natural Environment Research Council in Cambridge UK, where he was responsible for the establishment of the first cryopreserved biobank of algae and research on the basic mechanisms of freezing injury and tolerance in extreme environments, such as polar and alpine.

Harlan Knapp

Harlan Knapp

Business Development Manager - Upstream & Digital, A GE Healthcare Company

Harlan Knapp is Business Development Manager for Upstream & Digital at GE Life Sciences, aligning strategy and resources to implement robust upstream processes integrated into the Industrial Internet (IIoT). Harlan has been with GE for over 5 years as an Account Manager and Downstream Specialist. Prior to GE, he held roles as a Bioprocess Sales Engineer and Manager of Systems Integration & Automation. He received his Master’s in Biology from Eastern Washington University. He resides in Seattle, WA with his wife and 4 children where he creates life altering Espresso Coffee and spends time outdoors to round out his work-life balance.

Cell Therapy

Bioprocess